Diabetes mellitus

About

Since 1998 the “Diabetes Mellitus” (or “Sakharni Diabet”) Journal publishes timely articles, balancing both clinical and experimental research, case reports, reviews and lectures on pressing problems of diabetology. The Journal is aimed to provide a forum to discuss etiology and pathogenesis, clinical features, modern diagnostic and treatment approaches to diabetes mellitus and its complications, as well as associated conditions.

The Journal:

  • features original research articles, reflecting world diabetology development;
  • issues thematic editions on specific areas (diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, etc.);
  • publishes chronicle of major international congress sessions and workshops on diabetes mellitus, as well as state-of-the-art guidelines;
  • is intended for scientists, diabetologists, endocrinologists and specialists of allied trade, general practitioners, family physicians and pediatricians.

Editor-in-Chief

Ivan I. Dedov, PhD, Professor (ORCID: 0000-0002-8175-7886)

Indexation

The Diabetes Mellitus journal is currently indexed in Scopus (Elsevier), Emerging Sources Citation Index (Web of Science, Clarivate Analytics), Google Scholar, DOAJ and Russian Science Citation Index (eLibrary.ru).

Access to the content

All accepted articles in the Diabetes Mellitus journal are published in Gold Open Access (in accordance with Budapest Open Access Initiative) format with Free Full-text access to all articles via several websites (dia.endojournals.ruwww.elibrary.ruwww.cyberleninka.ru) and mobile applications for iOS® (available in AppStore). All accepted articles publish with the Creative Commons International license (CC BY-NC-ND 4.0) for more freely distribution and usage worlwide.

The journal is open for English and Russian language manuscripts. All English language manuscripts are published in bilingual format (with help of Russian association of endocrinologists the editorial team makes translations for all accepted english-language articles). So, the journal provide an additional readers auditory for published articles. 

Announcements

 

Ivan I. Dedov was elected an honorary foreign member of the French national medical academy

30 июня 2018 г. в Париже академик Российской Академии Наук Иван Иванович Дедов за многолетнее и плодотворное сотрудничество в области медицинской науки между Россией и Францией был удостоен почетным званием иностранного члена Французской национальной медицинской академии (ФНМА). 

23.08.2018
Posted: 23.08.2018
 
More Announcements...

Current Issue

Vol XX, No 2 (2019)

Original Studies

Contrast-induced nephropathy: the possibility of early diagnosis in patients with type 2 diabetes mellitus after primary percutaneous coronary interventions
Yarkova N., Borovkov N.
Abstract

Aim. To study the possibilities of early diagnosis of contrast-induced nephropathy (CIN) after primary percutaneous coronary interventions (PCI) in patients with type 2 diabetes mellitus (DM) using biostarers: cystatin C, nephrine and lipocalin-2.

Materials and methods. he study included 84 patients who received PCI for the first time. Before the PCI, the risk of CIN on the R. Mehran scale was assessed, and also modern biomarkers of renal damage were determined before and after the procedure for 3 days. All patients were divided into two groups: 1). patients with type 2 DM (n = 44 people); 2) patients without DM (n = 40 people). By sex, age, the duration of the disease group were comparable.

Results. The parameters of the functional state of the kidney before and after PCI in patients with type 2 DM, taking into account the criteria of KDIGO (2012) and elevated levels of modern biomarkers, indicated the development of CIN. In the control group, this was observed in 35 of 40 (87.5%) patients. In both groups, there was an increase in serum creatinine levels of blood, urea, new biomarkers, and a decrease in GFR after administration of contrast agents. Normalization of only urea and blood creatinine against the background of adequate hydration was detected on day 2-3 after contrasting procedures. The GFR remained still reduced despite ongoing therapy.

Conclusions. Cystatin C, nephrin, lipocalin 2 have high sensitivity and specificity. The determination within 3 days of these biomarkers allows us to objectively judge the dynamics of contrast-induced nephropathy in individuals with type 2 diabetes mellitus in surgical interventions on the coronary arteries with the introduction of contrast and the effectiveness of protective measures.

Diabetes mellitus. 2019;XX(2):
views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies